Cytotoxic electronegative LDL subfraction is present in human plasma

被引:90
作者
Demuth, K
Myara, I
Chappey, B
Vedie, B
PechAmsellem, MA
Haberland, ME
Moatti, N
机构
[1] HOP BROUSSAIS,BIOCHIM LAB,F-75674 PARIS,FRANCE
[2] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024
关键词
low-density lipoprotein; electronegativity; atherosclerotic risk factors; cytotoxicity; human umbilical vein endothelial cell;
D O I
10.1161/01.ATV.16.6.773
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
By using fast protein liquid chromatography, we isolated from human plasma a minor electronegative LDL subfraction designated LDL(-). After immunoaffinity chromatography against apolipoprotein (apo)(a) and apo A-I, LDL(-) represented 6.7+/-0.9% (mean+/-SD; n=18) of to al LDL. Compared with the major LDL subfraction, designated LDL(+), LDL(-) contained similar amounts of thiobarbituric acid-reactive substances, conjugated dienes, and vitamin E and had a similar lipid/protein ratio and mean density. Moreover, the apo B of LDL(-) was not aggregated and its LDL receptor-binding activity was slightly increased. These results were consistent with the nonoxidized nature of LDL(-). LDL(-) showed increased contents of sialic acid (38.1+/-5.2 versus 28.9+/-3.3 nmol/mg protein; n=7; P<.01), apo C-III (1.43+/-0.21% versus 0.14+/-0.04%; n=7;P<.01), and apo E (1.64+/-0.26% versus 0.10+/-0.05%; n=7; P<.0005). Compared with LDL(+), LDL(-) displayed enhanced cytotoxic effects on cultured human umbilical vein endothelial cells, as shown by lactate dehydrogenase assay (P<.003; n=6), neutral red uptake (P<.02; n=6), and morphological studies. We also studied the relationship of LDL(-) to age and plasma lipid levels in 133 subjects. The percentage of contribution of LDL(-) to total plasma LDL correlated with age (P<.05), total cholesterol (P<.05), and LDL cholesterol (P<.003). In conclusion, this study shows that LDL(-), a circulating human plasma LDL, is an electronegative native LDL subfraction with cytotoxic effects on endothelial cells. This subfraction, which correlates positively with common atherosclerotic risk factors, might induce atherogenesis by actively contributing to alteration of the vascular endothelium.
引用
收藏
页码:773 / 783
页数:11
相关论文
共 60 条
[1]   INTERACTION OF LPB, LPB-E, LPB-C-III, AND LPB-C-III-E LIPOPROTEINS WITH THE LOW-DENSITY-LIPOPROTEIN RECEPTOR OF HELA-CELLS [J].
AGNANI, G ;
BARD, JM ;
CANDELIER, L ;
DELATTRE, S ;
FRUCHART, JC ;
CLAVEY, V .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (04) :1021-1029
[2]   PRESENCE OF A MODIFIED LOW-DENSITY LIPOPROTEIN IN HUMANS [J].
AVOGARO, P ;
BON, GB ;
CAZZOLATO, G .
ARTERIOSCLEROSIS, 1988, 8 (01) :79-87
[3]   SOME QUESTIONS CONCERNING A SMALL, MORE ELECTRONEGATIVE LDL CIRCULATING IN HUMAN PLASMA [J].
AVOGARO, P ;
CAZZOLATO, G ;
BITTOLOBON, G .
ATHEROSCLEROSIS, 1991, 91 (1-2) :163-171
[4]   METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS [J].
BILHEIMER, DW ;
LEVY, RI ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :212-+
[5]   LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :223-261
[6]  
Bruckdorfer K. Richard, 1993, Current Opinion in Lipidology, V4, P238, DOI 10.1097/00041433-199306000-00010
[7]   CHARACTERIZATION OF A MORE ELECTRONEGATIVELY CHARGED LDL SUBFRACTION BY ION-EXCHANGE HPLC [J].
CAZZOLATO, G ;
AVOGARO, P ;
BITTOLOBON, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (03) :247-253
[8]  
CHAPMAN MJ, 1984, CIRCULATION, V70, P137
[9]   EVALUATION OF THE SIALIC-ACID CONTENT OF LDL AS A MARKER OF CORONARY CALCIFICATION AND EXTRACORONARY ATHEROSCLEROSIS IN ASYMPTOMATIC HYPERCHOLESTEROLEMIC SUBJECTS [J].
CHAPPEY, B ;
MYARA, I ;
GIRAL, P ;
KERHARO, G ;
PLAINFOSSE, MC ;
LEVENSON, J ;
SIMON, A ;
MOATTI, N ;
SEGOND, P ;
BADET, D ;
BAYLACLEBOT, C ;
BONNEAU, P ;
DEBONNIERES, A ;
BORIE, A ;
BOURILLON, MF ;
BOURSIER, J ;
BRESSLER, S ;
BRU, M ;
CHENET, M ;
CORTEEL, P ;
COULANGE, C ;
DELMOTTEDEVOCELLE, C ;
DEMURE, B ;
DOUGUET, MJ ;
DUBOST, M ;
DRUMARE, T ;
ESTEVE, D ;
FRAGNY, M ;
GALAMAND, O ;
GIARD, AM ;
GITEL, R ;
GUILBERT, C ;
HAGE, H ;
KIESGEN, F ;
LAMOTHE, E ;
LANOISELEE, C ;
LEBLANC, ML ;
LECHEVANTON, N ;
LEPRINCE, I ;
MARTY, A ;
MIARA, D ;
MILLET, B ;
OZIEL, J ;
PARINI, A ;
PASTEAU, MC ;
PICARD, M ;
PUPPONI, MM ;
QUINIO, C ;
RAULET, F ;
ROCCA, ML .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (03) :334-339
[10]  
CLAVEY V, 1991, ANN ENDOCRINOL-PARIS, V52, P459